These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 14762036)

  • 1. Antiphospholipid antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke.
    Levine SR; Brey RL; Tilley BC; Thompson JL; Sacco RL; Sciacca RR; Murphy A; Lu Y; Costigan TM; Rhine C; Levin B; Triplett DA; Mohr JP;
    JAMA; 2004 Feb; 291(5):576-84. PubMed ID: 14762036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: the PICSS-APASS study.
    Rajamani K; Chaturvedi S; Jin Z; Homma S; Brey RL; Tilley BC; Sacco RL; Thompson JL; Mohr JP; Levine SR;
    Stroke; 2009 Jul; 40(7):2337-42. PubMed ID: 19498198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid Antibodies and Recurrent Thrombotic Events: Persistence and Portfolio.
    Amory CF; Levine SR; Brey RL; Gebregziabher M; Tuhrim S; Tilley BC; Simpson AC; Sacco RL; Mohr JP;
    Cerebrovasc Dis; 2015; 40(5-6):293-300. PubMed ID: 26513489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ischemic stroke with antiphospholipid antibody].
    Kitagawa Y; Ohkuma H; Tokuoka K
    Brain Nerve; 2008 Oct; 60(10):1144-58. PubMed ID: 18975602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neurological aspects in antiphospholipid syndrome].
    Kitagawa Y
    Rinsho Shinkeigaku; 2003 Nov; 43(11):744-7. PubMed ID: 15152454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid antibodies in young adults with stroke.
    Brey RL
    J Thromb Thrombolysis; 2005 Oct; 20(2):105-12. PubMed ID: 16205859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticardiolipin antibodies and the risk of recurrent thrombo-occlusive events and death. The Antiphospholipid Antibodies and Stroke Study Group (APASS).
    Neurology; 1997 Jan; 48(1):91-4. PubMed ID: 9008500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subsequent Thrombotic Outcomes in Patients with Ischemic Stroke with Antiphospholipid Antibody Positivity.
    Pyo JY; Jung SM; Lee SW; Song JJ; Lee SK; Park YB
    Yonsei Med J; 2017 Nov; 58(6):1128-1134. PubMed ID: 29047236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do antiphospholipid antibodies increase the long-term risk of thrombotic complications in young patients with a recent TIA or ischemic stroke?
    van Goor MP; Alblas CL; Leebeek FW; Koudstaal PJ; Dippel DW
    Acta Neurol Scand; 2004 Jun; 109(6):410-5. PubMed ID: 15147465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study.
    Sacco RL; Prabhakaran S; Thompson JL; Murphy A; Sciacca RR; Levin B; Mohr JP;
    Cerebrovasc Dis; 2006; 22(1):4-12. PubMed ID: 16567931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
    Mohr JP; Thompson JL; Lazar RM; Levin B; Sacco RL; Furie KL; Kistler JP; Albers GW; Pettigrew LC; Adams HP; Jackson CM; Pullicino P;
    N Engl J Med; 2001 Nov; 345(20):1444-51. PubMed ID: 11794192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiphospholipid syndrome and stroke].
    Kitagawa Y
    Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG anticardiolipin antibody titer > 40 GPL and the risk of subsequent thrombo-occlusive events and death. A prospective cohort study.
    Levine SR; Salowich-Palm L; Sawaya KL; Perry M; Spencer HJ; Winkler HJ; Alam Z; Carey JL
    Stroke; 1997 Sep; 28(9):1660-5. PubMed ID: 9303006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiphospholipid antibodies in neonates with stroke--a unique entity or variant of antiphospholipid syndrome?
    Berkun Y; Simchen MJ; Strauss T; Menashcu S; Padeh S; Kenet G
    Lupus; 2014 Sep; 23(10):986-93. PubMed ID: 24729280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose aspirin vs low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial in patients positive for antiphospholipid antibodies (ALIWAPAS).
    Cuadrado MJ; Bertolaccini ML; Seed PT; Tektonidou MG; Aguirre A; Mico L; Gordon C; Ruiz-Irastorza G; Egurbide MV; Gil A; Espinosa G; Houssiau F; Rahman A; Martin H; McHugh N; Galindo M; Akil M; Amigo MC; Murru V; Khamashta MA
    Rheumatology (Oxford); 2014 Feb; 53(2):275-84. PubMed ID: 24097288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
    Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
    Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies.
    Ruiz-Irastorza G; Hunt BJ; Khamashta MA
    Arthritis Rheum; 2007 Dec; 57(8):1487-95. PubMed ID: 18050167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.